Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00224_DB00243_nanopub.RAq_PXZNpdvp2p-a2CHZAF15pBDICanmMtIR_jAzUELcE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00224_DB00243 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00224_DB00243 label "DDI between Indinavir and Ranolazine - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of ranolazine by decreasing its metabolism. Concomitant therapy is contraindicated. [drugbank_resource:DB00224_DB00243]" assertion.
- drugbank_resource:DB00224_DB00243 identifier "drugbank_resource:DB00224_DB00243" assertion.
- drugbank_resource:DB00224_DB00243 title "DDI between Indinavir and Ranolazine - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of ranolazine by decreasing its metabolism. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00243 assertion.
- drugbank:DB00243 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00243 assertion.